PCSK9 Inhibitors: Understanding the Pharmacist's Role in Patient Education and Improving Outcomes With Hyperlipidemia Management

PCSK9 Inhibitors: Understanding the Pharmacist’s Role in Patient Education and Improving Outcomes With Hyperlipidemia Management

Faculty

Joseph Saseen, PharmD, BCACP, BCPS, CLS
Professor and Vice Chair
Department of Clinical Pharmacy
Professor
Department of Family Medicine
University of Colorado Anschutz Medical Campus
Aurora, Colorado
 
Target Audience: Pharmacists
Type of Activity: Knowledge
Release date: December 18, 2020
Expiration date: December 18, 2021
Time to complete activity: 0.5 hour
Fee: Free

Educational Objectives
At the completion of this activity, participants will be able to:

• Understand the role of PCSK9 inhibitors in the American Heart Association and the American College of Cardiology hyperlipidemia management guidelines
• Review the pertinent drug information and clinical benefits of the use of PCSK9 inhibitors in the treatment of hyperlipidemia.
• Describe the role of the pharmacist in patient counseling and crucial education on PCSK9 inhibitors for the treatment of hyperlipidemia through motivational interviewing.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-20-400-H01-P. The activity is available for CE credit through December 18, 2021.


Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must listen to the podcast in its entirety and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
 

---

Disclosures

Joseph Saseen, PharmD, BCACP, BCPS, CLS, has no relevant financial relationships with commercial interests to disclose:

Pharmacy Times Continuing Education™ Planning Staff – Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Dipti Desai, PharmD, CHCP; Crissy Wilson; Susan Pordon; and Brianna Winters have no relevant financial relationships with commercial interests to disclose.

An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
ceinfo@pharmacytimes.com
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms